Five obesity-drug trends to watch in 2024: Who can compete with Eli Lilly and Novo Nordisk? 0 20.12.2023 19:17 MarketWatch.com The obesity drugs that powered huge investor gains in 2023 are poised to inspire more corporate dealmaking, scientific breakthroughs and better patient access in the year ahead, analysts say. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
